Search Results

Fundación MAPFRE, a global nonprofit foundation created by MAPFRE, announced it will donate $2.3 million to support urgent medical and community needs across Massachusetts, as the coronavirus continues to spread.

Provectus Biopharmaceuticals, Inc. were presented at the annual meeting of the Association for Research in Vision and Ophthalmology (“ARVO”), held May 5-9, 2024 in Seattle, Washington.

HTG Molecular Diagnostics, Inc. announced that the Fundación Instituto Valenciano de Oncología, located in Valencia, Spain, with its partners, the Fundación Pública Andaluza Progreso y Salud and the Centro de Investigación Biomédica en Red, have developed a laboratory-developed test for the assessment of breast cancer recurrence based on their use of the HTG EdgeSeq™ technology.

Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, announced that it is leading a consortium that has been awarded a €4 million grant from Horizon Europe, the European Union’s key funding program for research and innovation.

Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, may have developed a novel blood test that can be used to detect early-onset colorectal cancer, which has been on the rise in younger adults in recent years.